Explorer
Know how DRDO made the anti-COVID drug
An anti-Covid-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by INMAS, a lab of the Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy's Laboratories (DRL), Hyderabad.
Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.
India
Jharkhand: Jharkhand Government Holds Third Round of Talks With Student Groups Ahead of Assembly Gherao
Iran: New Video of Iran’s Mustafa Khamenei Raises Fresh Questions Over His Health
Uttar Pradesh Politics: Yogi Government Launches ‘Mission Gen-Z’ Ahead of 2027 UP Assembly Elections
Aviation: Air India Turbulence Incident Under DGCA Probe, Captain’s Drug Test Reportedly Being Examined
Jharkhand Politics: BJP Claims Rahul Gandhi Pressuring Hemant Soren Over JPSC-JSSC Row
View More
Top Headlines
World
'I Know How To Stand My Ground': Netanyahu Rejects 'Great Friend' Trump’s Gaza Plan
Cities
Mamata’s Car Attacked With Stones, Mud Smeared; ‘Thief, Thief’ Chants Raised | WATCH
Cities
‘We Have Caught Theft’: Hemant Soren Assures Justice To JPSC-JSSC Protesters
Cities
Malaysia Airlines Flight With 159 Onboard Hit By Laser Beam Near Kolkata Airport
Trending News
